Features of correction of clinical manifestations in patients with non-alcoholic steatohepatitis and diabetic kidney disease against the background of type 2 diabetes

Abstract

The relevance of finding optimal methods of treatment for patients with a comorbid course of nonalcoholic steatohepatitis (NASH) that developed against the background of type 2 diabetes mellitus (DM2) is due to the fact that these diseases have a number of common cause-and-effect mechanisms, and under the conditions of the development of diabetic kidney disease (DКD) also has a number of mechanisms of mutual encumbrance.